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1413New Oral Anticoagulants for Atrial Fibrillation
and Acute Coronary SyndromesRaffaele De Caterina, Steen Husted, Lars Wallentin, Felicita Andreotti, Harald Arnesen, Fedor Bachmann,
Colin Baigent, Kurt Huber, Jø´rgen Jesepersen, Steen Dalby Kristensen, Gregory Y. H. Lip, João Morais,
Lars Hvilsted Rasmussen, Agneta Siegbahn, Freek W. A. Verheugt, Jeffrey I. Weitz
In this paper, members of the European Society of Cardiology Task Force on Anticoagulants
review several new oral anticoagulants. These anticoagulants all target single coagulation
enzymes, thrombin (dabigatran) or factor Xa (apixaban, rivaroxaban, and edoxaban), and are
given in fixed doses without coagulation monitoring. For use in patients with atrial
fibrillation, comparing the drugs is difficult because of differences in trial design, but there was
a consistency towards similar or lower rates of systemic embolism along with similar or lower
rates of bleeding complications compared to vitamin K agonists. The pharmacology and
specific clinical trials are reviewed for each of these agents.CLINICAL RESEARCH ACUTE MYOCARDIAL INFARCTION1426Oxidized Phospholipids, Plasminogen, and Acute Myocardial InfarctionGregor Leibundgut, Kiyohito Arai, Alexina Orsoni, Huiyong Yin, Corey Scipione, Elizabeth R. Miller,
Marlys L. Koschinsky, M. John Chapman, Joseph L. Witztum, Sotirios Tsimikas
Plasminogen is activated to plasmin which helps to degrade fibrin-rich thrombi. Plaminogen
is homologous to lipoprotein (a) [Lp(a)] which is known to bind pro-inflammatory oxidized
phospholipids (OxPL) and the number of these OxPL particles correlates with cardiac risk.
Leibundgut and colleagues confirmed that OxPL also bind to plasminogen using mass
spectometry. Plasma levels of OxPL/plasminogen in humans did not correlate with Lp(a) and
were stable over time except in patients with a recent myocardial infarction, after which they
increased. In another set of in vitro experiments, removal of OxPL from plasminogen resulted
in a longer lysis time of fibrin clots suggesting that these particles actually facilitate
thrombolysis when attached to plasminogen.
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cHEART FAILURE1441Peak Expiratory Flow Rate May Be a Useful Tool for Assessing Cardiac DyspneaJustin A. Ezekowitz, Adrian F. Hernandez, Christopher M. O’Connor, Randall C. Starling, Gyt Proulx,
Mason H. Weiss, Jeffrey A. Bakal, Robert M. Califf, John J. V. McMurray, Paul W. Armstrong
Ezekowitz and colleagues hypothesized that peak expiratory flow rate (PEFR) would increase
with treatment over the first 24 h in patients presenting with acute decompensated heart
failure (ADHF). Dyspnea is a key symptom and clinical trial endpoint in ADHF trials yet it
is not an objective measurement. In a clinical trial substudy, 421 patients underwent PEFR
testing at baseline, 1, 6, and 24 h after randomization to nesiritide or placebo. The Dyspnea
Index (DI) was collected with the Likert scale. Baseline PEFR was 225 l/min and increased
2.2% by hour 1, 11% by hour 6, and 21% by 24 h. The objective change in PEFR correlated
with the subjective DI and may increase the statistical power of studies designed to relieve
symptoms in patients with ADHF.Editorial Comment: J. Malcolm O. Arnold, Liane Porepa, page 1449.VALVULAR HEART DISEASE1452Do Bisphosphonates Slow the Progression of Aortic Stenosis?Olcay Aksoy, Akin Cam, Sachin S. Goel, Penny L. Houghtaling, Sarah Williams, Ernesto Ruiz-Rodriguez,
Venu Menon, Samir R. Kapadia, E. Murat Tuzcu, Eugene H. Blackstone, Brian P. Griffin
Valvular calcification is associated with the development and progression of aortic stenosis
(AS) leading to the theory that bisphosphonates could slow its progression. Aksoy and
colleagues reviewed echocardiograms of female patients over 60 years of age with moderate
aortic stenosis who had another at least 1 year later. A total of 38% of the subjects were
taking bisphosphonates at the time of their initial echocardiogram. There were no differences
in the rate of change in valve area when patients were propensity-matched for the use of
bisphosphonates. These results suggest that bisphosphonates are unlikely to have a significant
impact on the hemodynamic or clinical progression of AS.ELECTROCARDIOGRAM AND STROKE1460Prolonged QTc Interval Linked to Increased Risk of StrokeElsayed Z. Soliman, George Howard, Mary Cushman, Brett Kissela, Dawn Kleindorfer, Anh Le,
Suzanne Judd, Leslie A. McClure, Virginia J. Howard
A prolonged heart rate-corrected QT interval (QTc) has been linked to increased cardiac risk.
Soliman and colleagues investigated whether a prolonged QTc was also associated with an
increased risk of stroke using data from almost 30,000 subjects. At baseline, 2.7% of the
participants had a prolonged QTcFram ( 460 ms in men or 450 ms in women). During up
o 8.2 years of follow-up, 5.4% of participants with prolonged QTcFram developed stroke
ompared to only 2.8% of those with normal QTcFram. After adjustment for multiple stroke
risk factors and the use of QT-prolonging drugs, the risk of stroke remained significantly
higher (hazard ratio: 1.67). QTc prolongation is associated with a significantly increased risk
of incident stroke independent of known stroke risk factors.(continued on page A-22)
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Eric Rosenthal, Shakeel A. Qureshi
Chubb and colleagues investigated the long-term outcomes for patients undergoing catheter
valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) 21 years after
the first procedure at their institution. There were 37 successful valve perforations out of
39 attempts. Median length of follow-up was 9.2 years. There were 8 deaths (21%), but no
deaths after the first 35 days. A total of 25 patients (83% of survivors) have a biventricular
circulation. For patients who had stenting of the arterial duct, significant reductions in early
reintervention and hospital stay occurred, with no increase in mortality. Long-term
survival is good, and even small right ventricles may be amenable to catheter valve
perforation in patients with PAIVS.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH1477Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac DamageYi Tan, Xiaokun Li, Sumanth D. Prabhu, Kenneth R. Brittian, Qiang Chen, Xia Yin, Craig J. McClain,
Zhanxiang Zhou, Lu Cai
Tan and colleagues examined the cellular and molecular mechanisms underlying alcoholic
cardiomyopathy in a mouse model. Hearts from mice fed alcohol for 2 months exhibited
increased apoptosis and nitrative damage. In a cellular model, alcohol exposure significantly
increased the expression of angiotensin II and its type 1 receptor (AT1). Mice with knockout
of AT1 gene did not develop cardiac nitrative damage, cell death, or cardiac dysfunction
when exposed to alcohol. These results help clarify the pathophysiology of alcohol-induced
cardiac damage and suggest that angiotensin receptor blockers may be highly effective
treatments for limiting further damage.
